非小细胞肺癌寡转移如何治疗？一文解析

导语：肺癌「寡转移」的由来、定义及治疗策略

本材料由阿斯利康提供，仅供医疗卫生专业人士参考

审批编号：CN-140521 过期日期：2024-8-31

内容审核：nyh

项目审核：杨静

题图来源：站酷海洛plus

参考文献

[1]Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8-10.

[2]Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.

[3]Iyengar P, All S, Berry MF, et al. Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline. Pract Radiat Oncol. 2023;13(5):393-412.

[4] Harrow S, Palma DA, Olson R, et al. Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes. Int J Radiat Oncol Biol Phys. 2022;114(4):611-616.

[5]宫莉营,刘文健.非小细胞肺癌寡转移及其放射治疗研究进展[J].社区医学杂志, 2022, 20(6):5.

[6]Liu W, Bahig H, Palma DA. Oligometastases: Emerging Evidence. J Clin Oncol. 2022 Dec 20;40(36):4250-4260.

[7]Dingemans AC, Hendriks LEL, Berghmans T, et al. Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. J Thorac Oncol. 2019;14(12):2109-2119.

[8]2024版中国临床肿瘤学会（CSCO）非小细胞肺癌诊疗指南.